Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 2401 AL 2415

The Role of Genetic Testing for Parkinson's Disease

Cook L, Schulze J, Naito A, Alcalay RN.

Curr Neurol Neurosci Rep. 2021 Mar 8;21(4):17. doi: 10.1007/s11910-021-01100-7.

Case Report: Bupropion Reduces the [(123)I]FP-CIT Binding to Striatal Dopamine Transporter

Milenkovic I, Bartova L, Papageorgiou K, Kasper S, Traub-Weidinger T, Winkler D.

Front Psychiatry. 2021 Feb 22;12:631357. doi: 10.3389/fpsyt.2021.631357. eCollection 2021.

Characterisation of advanced Parkinson's disease: OBSERVE-PD observational study - results of the Swiss subgroup

Möller JC, Baumann CR, Burkhard PR, Kaelin-Lang A, Küng I, Onuk K, Bohlhalter S.

Swiss Med Wkly. 2021 Mar 6;151:w20419. doi: 10.4414/smw.2021.20419. eCollection 2021 Mar 1.

Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment

Dobkin RD, Mann SL, Weintraub D, Rodriguez KM, Miller RB, St Hill L, King A, Gara MA, Interian A.

Mov Disord. 2021 Nov;36(11):2549-2558. doi: 10.1002/mds.28548. Epub 2021 Mar 12.

Voltage-Gated Ca(2+) Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?

Ortner NJ.

Front Synaptic Neurosci. 2021 Feb 26;13:636103. doi: 10.3389/fnsyn.2021.636103. eCollection 2021.

Spectrum of Non-Motor Symptoms in Parkinson's Disease

Kumaresan M, Khan S.

Cureus. 2021 Feb 11;13(2):e13275. doi: 10.7759/cureus.13275.

Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease

Dong J, Hawes S, Wu J, Le W, Cai H.

Front Neural Circuits. 2021 Mar 2;15:645287. doi: 10.3389/fncir.2021.645287. eCollection 2021.

The Phenomenon of Exquisite Motor Control in Tic Disorders and its Pathophysiological Implications

Ganos C, Neumann WJ, Müller-Vahl KR, Bhatia KP, Hallett M, Haggard P, Rothwell J.

Mov Disord. 2021 Jun;36(6):1308-1315. doi: 10.1002/mds.28557. Epub 2021 Mar 19.

Sleep disturbance in movement disorders: insights, treatments and challenges

Bailey GA, Hubbard EK, Fasano A, Tijssen MA, Lynch T, Anderson KN, Peall KJ.

J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):723-736. doi: 10.1136/jnnp-2020-325546. Epub 2021 Mar 19.

Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker

Gaurav R, Yahia-Cherif L, Pyatigorskaya N, Mangone G, Biondetti E, Valabrègue R, Ewenczyk C, Hutchison RM, Cedarbaum JM, Corvol JC, Vidailhet M, Lehéricy S.

Mov Disord. 2021 Jul;36(7):1592-1602. doi: 10.1002/mds.28531. Epub 2021 Mar 10.

Biosensors in Parkinson's disease

Mobed A, Razavi S, Ahmadalipour A, Shakouri SK, Koohkan G.

Clin Chim Acta. 2021 Jul;518:51-58. doi: 10.1016/j.cca.2021.03.009. Epub 2021 Mar 19.

Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder

de Almeida CMO, Brito MMC, Bosaipo NB, Pimentel AV, Tumas V, Zuardi AW, Crippa JAS, Hallak JEC, Eckeli AL.

Mov Disord. 2021 Jul;36(7):1711-1715. doi: 10.1002/mds.28577. Epub 2021 Mar 22.

Claims-Based Frailty and Outcomes: Applying an Aging Measure to Older Adults with Parkinson's Disease

Abraham DS, Pham Nguyen TP, Willis AW.

Mov Disord. 2021 Aug;36(8):1871-1878. doi: 10.1002/mds.28561. Epub 2021 Mar 23.

Association of Parkinson's Disease With Microbes and Microbiological Therapy

Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, Li XF, Gao BL.

Front Cell Infect Microbiol. 2021 Mar 8;11:619354. doi: 10.3389/fcimb.2021.619354. eCollection 2021.

A Phase 2 Proof-of-Concept, Randomized, Placebo-Controlled Trial of CX-8998 in Essential Tremor

Papapetropoulos S, Lee MS, Versavel S, Newbold E, Jinnah HA, Pahwa R, Lyons KE, Elble R, Ondo W, Zesiewicz T, Hedera P, Handforth A, Elder J, Versavel M.

Mov Disord. 2021 Aug;36(8):1944-1949. doi: 10.1002/mds.28584. Epub 2021 Mar 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias